Gepotidacin and Zoliflodacin: The New Gonorrhea Antibiotics Explained

You did not plan to be Googling antibiotic names on your Pattaya holiday. Maybe the symptoms showed up a few days in. Maybe you picked something up from a pharmacy down the road and it did not work. Either way, you are in the right place now.

Gonorrhea is changing fast. The bacteria behind it have developed resistance to one antibiotic after another, and the pipeline for new treatments was essentially empty for three decades. Gepotidacin and zoliflodacin are the drugs that finally changed that. This article explains what they are, what the trial results showed, what the resistance picture looks like right here in Pattaya, and what your practical options are today.

Why Gonorrhea Needed New Antibiotics Urgently

For a long time, gonorrhea was straightforward to treat. Then it became resistant to penicillin, then tetracycline, then fluoroquinolones, then azithromycin. Ceftriaxone, given by injection, became the last reliable option. Now resistant strains of that are appearing too.

The phrase "super-gonorrhea" is not dramatic shorthand. It describes real strains that existing antibiotics struggle to clear. Gepotidacin and zoliflodacin are not modifications of older drugs. They belong to entirely new drug classes, which means bacteria resistant to ceftriaxone or azithromycin are not automatically resistant to these.

How Gepotidacin and Zoliflodacin Work

Both drugs block enzymes that gonorrhea bacteria need to copy their DNA. Without those enzymes working, the bacteria cannot reproduce and the infection clears.

Gepotidacin hits two bacterial targets at once, which makes it much harder for resistance to develop through a single mutation. Zoliflodacin targets a completely different site that existing antibiotics do not touch, so current resistance patterns simply do not apply to it. That is the part that matters for patients. Neither drug cares about the resistance history of the strain it is treating.

What the Clinical Trials Actually Showed

Gepotidacin was tested in the EAGLE-1 phase 3 trial against the current standard treatment. It achieved a microbiological cure rate of around 92.6 percent. Zoliflodacin reached approximately 90.9 percent in its own phase 3 trial. Both are strong results.

Dosing is worth knowing about. Gepotidacin is taken as two oral doses of 3000 mg, roughly 12 hours apart, with food. Zoliflodacin is a single 3 gram dose dissolved in water. Both are oral. No injection required, which is a meaningful shift from the current standard where treatment usually means coming in for a ceftriaxone shot.

Side effects exist. Gepotidacin causes more gastrointestinal symptoms, mainly nausea and diarrhoea. Zoliflodacin appears better tolerated in that regard, though data are still building.

Does It Work for Throat and Rectal Gonorrhea?

This comes up often in Pattaya, so let’s deal with it directly.

Both drugs were primarily trialled and approved for uncomplicated urogenital gonorrhea. Gepotidacin showed effectiveness against rectal gonorrhea in trial sub-analyses. Pharyngeal gonorrhea, meaning throat infection, is a different story. There were two reported treatment failures in pharyngeal cases in the gepotidacin data. For zoliflodacin, evidence at non-urogenital sites is still limited.

If your exposure involved throat or rectal contact, do not assume oral tablets cover every site equally. Come in, get swabbed at the relevant sites, and we match treatment to what we actually find.

Drug-Resistant Gonorrhea in Pattaya — This Is Not a Distant Problem

A lot of articles about resistant gonorrhea cite global trends. Here is what is happening locally.

A June 2026 CDC Emerging Infectious Diseases report confirmed ceftriaxone-resistant gonorrhea, specifically penA-60 strains, at STI clinics in Pattaya, Chonburi Province. Many of those cases involved patients who had self-treated with pharmacy azithromycin before seeing a doctor.

Pattaya sees high rates of sexual contact across a transient population. Tourists stay for days or weeks, infections spread, people self-treat, and resistant strains develop. The cycle reinforces itself. Having access to proper diagnosis and current treatment knowledge in this city is not a minor point.

Why Buying Antibiotics at a Pattaya Pharmacy Will Make Things Worse

The logic is understandable. You notice symptoms, you find a pharmacy, you pick up something familiar. It is cheap and quick. It is also one of the main reasons resistant gonorrhea is spreading here.

Azithromycin is widely available over the counter in Pattaya and is no longer reliably effective against gonorrhea. Taking it masks symptoms temporarily while resistance builds. You feel slightly better, stop the course, the infection persists, and the next person who contracts it now has a harder-to-treat strain. Published data have documented this exact pattern in patients presenting to Pattaya STI clinics.

Self-treatment is not a shortcut. It is a delay that costs you and anyone around you. A confirmed diagnosis from a swab or urine test, followed by the right antibiotic at the right dose, is the only way this works properly.

Gepotidacin vs Zoliflodacin — A Practical Comparison

Are These Drugs Available in Pattaya or Thailand Right Now?

Honestly, not yet in standard clinical practice. Both drugs received FDA approval in December 2025. Availability outside the United States remains limited through 2026, and neither is confirmed in standard Thai clinical supply at this point. WHO guideline updates incorporating these drugs are expected from a mid-2026 review, which will shape adoption in Thailand and across Southeast Asia.

What this means practically: if you come to Doctor Pattaya with gonorrhea symptoms, we test you, confirm the diagnosis, and treat you with the best available option for your case. For most patients right now, that is still injectable ceftriaxone at the correct dose. If there is clinical reason to suspect resistance, we discuss that with you directly and manage accordingly. As gepotidacin and zoliflodacin become available through licensed supply channels in Thailand, we will use them.

Do not try to source these drugs independently online. Quality outside regulated supply chains cannot be guaranteed.

What Happens After Treatment — The Test of Cure

Treatment is not the end of the process. A follow-up test to confirm the infection has actually cleared is an important step, particularly with resistant strains in the picture.

For standard gonorrhea, a test of cure is generally recommended around two weeks after treatment. For cases where resistance is suspected or confirmed, follow-up matters even more. Come back, get checked, and close the loop properly. It takes minutes.

Partner Treatment and Preventing Reinfection

If you test positive, your partner needs treatment at the same time. Treating one person while the other goes untreated just leads to reinfection, and a reinfection can bring a resistant strain back into the picture.

In Pattaya, where contact networks are often complex and partners may be transient, this is harder to manage. But if a contact is reachable, tell them. We can advise on handling this confidentially. Reinfection after successful treatment is common when partners are not treated, and it is entirely avoidable.